Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy?

• Главные авторы: Vuković-Dejanović Vesna (Автор), Spasojević-Kalimanovska Vesna (Автор), Kalimanovska-Oštrić Dimitra (Автор), Bogavac-Stanojević Nataša (Автор)
• Формат: ‌
• Опубликовано: Pharmaceutical Association of Serbia, Belgrade, Serbia, 2022-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin family that provides useful prognostic information and facilitates diagnosti...